APPLICATION
NDA205840
TYPE
NDA
ORIGINAL APPROVAL
2013-07-16
LATEST ACTION
2013-07-16
ROUTE
RESPIRATORY (INHALATION), CUTANEOUS, INHALATION
DOSAGE FORM
GAS
MARKETING STATUS
Prescription
Products
OXYGEN, USPPrescription
OXYGEN N/A · GAS · INHALATION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.